Increased risk of non-alcoholic fatty liver disease (NAFLD) is associated with obesity . Sustained weight loss helps improve insulin resistance and associated NAFLD.

Some pharmacological agents have shown initial improvement but none has established long-term efficacy to improve insulin resistance and pro-inflammatory mediators potentially responsible for the progression of NAFLD. Bariatric surgery may play a crucial role in such a scenario.